{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:25:28Z","timestamp":1789500328496,"version":"build-2803163510"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T00:00:00Z","timestamp":1616025600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T00:00:00Z","timestamp":1616025600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s11255-021-02834-6","type":"journal-article","created":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T19:38:11Z","timestamp":1616096291000},"page":"157-163","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Antibiotic dosing adjustments in hospitalized patients with chronic kidney disease: a retrospective chart review"],"prefix":"10.1007","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4204-359X","authenticated-orcid":false,"given":"Bahia","family":"Chahine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,18]]},"reference":[{"issue":"10225","key":"2834_CR1","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","volume":"395","author":"GBD Chronic Kidney Disease Collaboration","year":"2020","unstructured":"GBD Chronic Kidney Disease Collaboration (2020) Global, regional, and national burden of chronic kidney disease, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 395(10225):709\u2013733. https:\/\/doi.org\/10.1016\/S0140-6736(20)30045-3","journal-title":"Lancet"},{"issue":"1","key":"2834_CR2","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1038\/s41598-020-59794-7","volume":"10","author":"CH Chang","year":"2020","unstructured":"Chang CH, Fan PC, Kuo G et al (2020) Infection in advanced chronic kidney disease and subsequent adverse outcomes after dialysis initiation: a nationwide cohort study. Sci Rep. 10(1):2938. https:\/\/doi.org\/10.1038\/s41598-020-59794-7 (Published 2020 Feb 19)","journal-title":"Sci Rep."},{"issue":"1","key":"2834_CR3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1053\/j.ackd.2019.08.001","volume":"27","author":"MC Morales-Alvarez","year":"2020","unstructured":"Morales-Alvarez MC (2020) Nephrotoxicity of antimicrobials and antibiotics. Adv Chronic Kidney Dis 27(1):31\u201337. https:\/\/doi.org\/10.1053\/j.ackd.2019.08.001","journal-title":"Adv Chronic Kidney Dis"},{"key":"2834_CR4","doi-asserted-by":"publisher","unstructured":"Lea-Henry TN, Carland JE, Stocker SL, Sevastos J, Roberts DM (2018) CJASN 13(7):1085\u20131095. https:\/\/doi.org\/10.2215\/CJN.00340118","DOI":"10.2215\/CJN.00340118"},{"issue":"5","key":"2834_CR5","doi-asserted-by":"publisher","first-page":"634","DOI":"10.3109\/0886022X.2012.660855","volume":"34","author":"I Kocyigit","year":"2012","unstructured":"Kocyigit I, Dortdudak S, Sipahioglu M et al (2012) Levofloxacin-induced delirium: is it a dangerous drug in patients with renal dysfunction? Ren Fail 34(5):634\u2013636. https:\/\/doi.org\/10.3109\/0886022X.2012.660855","journal-title":"Ren Fail"},{"issue":"8","key":"2834_CR6","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1093\/cid\/ciu027","volume":"58","author":"JA Roberts","year":"2014","unstructured":"Roberts JA, Paul SK, Akova M et al (2014) DALI: defining antibiotic levels in intensive care unit patients: are current \u03b2-lactam antibiotic doses sufficient for critically ill patients? Clin Infect Dis 58(8):1072\u20131083. https:\/\/doi.org\/10.1093\/cid\/ciu027","journal-title":"Clin Infect Dis"},{"key":"2834_CR7","first-page":"1454","volume":"76","author":"SW Lam","year":"2007","unstructured":"Lam SW, Eschenauer GA (2007) Identifying patients at risk of chronic kidney disease. Am Fam Physician 76:1454","journal-title":"Am Fam Physician"},{"issue":"4","key":"2834_CR8","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1002\/jcph.604","volume":"56","author":"GR Matzke","year":"2016","unstructured":"Matzke GR, Dowling TC, Marks SA, Murphy JE (2016) Influence of kidney disease on drug disposition: an assessment of industry studies submitted to the FDA for new chemical entities 1999\u20132010. J Clin Pharmacol 56(4):390\u2013398","journal-title":"J Clin Pharmacol"},{"issue":"6","key":"2834_CR9","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.2215\/CJN.06870909","volume":"5","author":"WM Michels","year":"2010","unstructured":"Michels WM, Grootendorst DC, Verduijn M, Elliott EG, Dekker FW, Krediet RT (2010) Performance of the Cockcroft-Gault, MDRD, and new CKD-EPI formulas in relation to GFR, age, and body size. Clin J Am Soc Nephrol 5(6):1003\u20131009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"2834_CR10","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1177\/1060028019890346","volume":"54","author":"AK Lew","year":"2020","unstructured":"Lew AK, Crass RL, Eschenauer G (2020) Evolution of equations for estimating renal function and their application to the dosing of new antimicrobials. Ann Pharmacother 54(5):496\u2013503. https:\/\/doi.org\/10.1177\/1060028019890346","journal-title":"Ann Pharmacother"},{"issue":"1","key":"2834_CR11","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1053\/j.ackd.2017.10.003","volume":"25","author":"JQ Hudson","year":"2018","unstructured":"Hudson JQ, Nolin TD (2018) Pragmatic use of kidney function estimates for drug dosing: the tide is turning. Adv Chronic Kidney Dis 25(1):14\u201320. https:\/\/doi.org\/10.1053\/j.ackd.2017.10.003","journal-title":"Adv Chronic Kidney Dis"},{"key":"2834_CR12","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1093\/ndt\/gfu191","volume":"30","author":"M Gallieni","year":"2015","unstructured":"Gallieni M, Cancarini G (2015) Drugs in the elderly with chronic kidney disease: beware of potentially inappropriate medications. Nephrol Dial Transpl 30:342\u2013344","journal-title":"Nephrol Dial Transpl"},{"issue":"3","key":"2834_CR13","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0272-6386(83)80060-2","volume":"3","author":"WM Bennett","year":"1983","unstructured":"Bennett WM, Aronoff GR, Morrison G et al (1983) Drug prescribing in renal failure: dosing guidelines for adults. Am J Kidney Dis 3(3):155\u2013193","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"2834_CR14","doi-asserted-by":"publisher","first-page":"e0158677","DOI":"10.1371\/journal.pone.0158677","volume":"11","author":"A Saleem","year":"2016","unstructured":"Saleem A, Masood I (2016) Pattern and predictors of medication dosing errors in chronic kidney disease patients in pakistan: a single center retrospective analysis. PLoS ONE 11(7):e0158677. https:\/\/doi.org\/10.1371\/journal.pone.0158677 (Published 2016 Jul 1)","journal-title":"PLoS ONE"},{"issue":"8","key":"2834_CR15","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1002\/pds.1412","volume":"16","author":"WM Sweileh","year":"2007","unstructured":"Sweileh WM, Janem SA, Sawalha AF et al (2007) Medication dosing errors in hospitalized patients with renal impairment: a study in Palestine. Pharmacoepidemiol Drug Saf 16(8):908\u2013912. https:\/\/doi.org\/10.1002\/pds.1412","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2834_CR16","doi-asserted-by":"publisher","unstructured":"Laville SM, Gras-Champel V, Moragny J, Metzger M, Jacquelinet C, Combe C, Fouque D, Laville M, Frimat L, Robinson BM, Stengel B, Massy ZA, Liabeuf S, on behalf of the Chronic Kidney Disease-Renal Epidemiology and Information Network (CKD-REIN) Study Group CJASN 15(8):1090\u20131102; https:\/\/doi.org\/10.2215\/CJN.01030120","DOI":"10.2215\/CJN.01030120"},{"key":"2834_CR17","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/1471-2407-4-94","volume":"4","author":"WH Hall","year":"2004","unstructured":"Hall WH, Ramachandran R, Narayan S, Jani AB, Vijayakumar S (2004) An electronic application for rapidly calculating Charlson comorbidity score. BMC Cancer 4:94. https:\/\/doi.org\/10.1186\/1471-2407-4-94","journal-title":"BMC Cancer"},{"key":"2834_CR18","unstructured":"Wolters Kluwer. Lexicomp. Database. https:\/\/www.wolterskluwercdi.com\/lexicomp-online\/. Accessed 19 Aug 2020"},{"issue":"9","key":"2834_CR19","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1080\/14787210.2020.1764845","volume":"18","author":"SM Jang","year":"2020","unstructured":"Jang SM, Lewis SJ, Mueller BA (2020) Harmonizing antibiotic regimens with renal replacement therapy. Expert Rev Anti Infect Ther 18(9):887\u2013895. https:\/\/doi.org\/10.1080\/14787210.2020.1764845","journal-title":"Expert Rev Anti Infect Ther"},{"key":"2834_CR20","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group (2013) KDIGO clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 3:1\u2013150"},{"issue":"10","key":"2834_CR21","doi-asserted-by":"publisher","first-page":"e13579","DOI":"10.1111\/ijcp.13579","volume":"74","author":"F Jarab","year":"2020","unstructured":"Jarab F, Jarab AS, Mukattash TL, Nusairat B, Alshogran OY (2020) Antibiotic dosing adjustments in patients with declined kidney function at a tertiary hospital in Jordan. Int J Clin Pract 74(10):e13579. https:\/\/doi.org\/10.1111\/ijcp.13579","journal-title":"Int J Clin Pract"},{"key":"2834_CR22","doi-asserted-by":"publisher","unstructured":"Silva M, Dias G, Cardoso T (2020) Estimated Creatinine Clearance and Glomerular Filtration Rate in Very Elderly Patients and Antibiotic Prescribing Errors: Cohort Study [published online ahead of print, 2020 Jul 29]. Acta Med Port. 2020;https:\/\/doi.org\/10.20344\/amp.12408. https:\/\/doi.org\/10.20344\/amp.12408","DOI":"10.20344\/amp.12408 10.20344\/amp.12408"},{"key":"2834_CR23","unstructured":"Reza A, Maini M, Hossein S (2019) Evaluation of antibiotic dose adjustment based on glomerular filtration rate in Patients who were admitted to rasool-akram hospital, Tehran, in 6months of 2015. J Adv Pharm Edu Res 9(S):183\u2013187"},{"issue":"3","key":"2834_CR24","first-page":"655","volume":"30","author":"R Zeenny","year":"2014","unstructured":"Zeenny R, Nasr Z, Adaimy I (2014) Retrospective evaluation of the appropriate use of Piperacillin\/Tazobactam in a tertiary care teaching hospital in Lebanon. Acta Medica Mediterranea 30(3):655\u2013663","journal-title":"Acta Medica Mediterranea"},{"issue":"11","key":"2834_CR25","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1016\/j.jsps.2020.09.015","volume":"28","author":"NA Alsaleh","year":"2020","unstructured":"Alsaleh NA, Al-Omar HA, Mayet AY, Mullen AB (2020) Evaluating the appropriateness of carbapenem and piperacillin-tazobactam prescribing in a tertiary care hospital in Saudi Arabia. Saudi Pharm J 28(11):1492\u20131498. https:\/\/doi.org\/10.1016\/j.jsps.2020.09.015","journal-title":"Saudi Pharm J"},{"issue":"1","key":"2834_CR26","first-page":"157","volume":"11","author":"F Fahimi","year":"2012","unstructured":"Fahimi F, Emami S, Rashid FF (2012) The rate of antibiotic dosage adjustment in renal dysfunction. Iran J Pharm Res 11(1):157\u2013161","journal-title":"Iran J Pharm Res"},{"issue":"9","key":"2834_CR27","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1248\/yakushi.17-00002","volume":"137","author":"T Morimoto","year":"2017","unstructured":"Morimoto T, Nagashima H, Morimoto Y, Tokuyama S (2017) Frequency of acute kidney injury caused by Tazobactam\/Piperacillin in patients with pneumonia and chronic kidney disease: a retrospective observational study. Yakugaku Zasshi 137(9):1129\u20131136. https:\/\/doi.org\/10.1248\/yakushi.17-00002","journal-title":"Yakugaku Zasshi"},{"issue":"7","key":"2834_CR28","doi-asserted-by":"publisher","first-page":"e12960","DOI":"10.1111\/ijcp.12960","volume":"71","author":"WH Tesfaye","year":"2017","unstructured":"Tesfaye WH, Castelino RL, Wimmer BC et al (2017) Inappropriate prescribing in chronic kidney disease: a systematic review of prevalence, associated clinical outcomes and impact of interventions. Int J Clin Pract 71(7):e12960","journal-title":"Int J Clin Pract"},{"issue":"12","key":"2834_CR29","first-page":"730","volume":"66","author":"DC Fiore","year":"2017","unstructured":"Fiore DC, Fettic LP, Wright SD, Ferrara BR (2017) Antibiotic overprescribing: Still a major concern. J Fam Pract 66(12):730\u2013736","journal-title":"J Fam Pract"},{"issue":"7\u20138","key":"2834_CR30","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1345\/aph.1G742","volume":"40","author":"EA van Dijk","year":"2006","unstructured":"van Dijk EA, Drabbe NR, Kruijtbosch M, De Smet PA (2006) Drug dosage adjustments according to renal function at hospital discharge. Ann Pharmacother 40(7\u20138):1254\u20131260. https:\/\/doi.org\/10.1345\/aph.1G742","journal-title":"Ann Pharmacother"},{"issue":"5","key":"2834_CR31","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.ajem.2018.07.052","volume":"37","author":"BD Kulwicki","year":"2019","unstructured":"Kulwicki BD, Brandt KL, Wolf LM, Weise AJ, Dumkow LE (2019) Impact of an emergency medicine pharmacist on empiric antibiotic prescribing for pneumonia and intra-abdominal infections. Am J Emerg Med 37(5):839\u2013844. https:\/\/doi.org\/10.1016\/j.ajem.2018.07.052","journal-title":"Am J Emerg Med"},{"issue":"10","key":"2834_CR32","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1345\/aph.1M187","volume":"43","author":"Y Hassan","year":"2009","unstructured":"Hassan Y, Al-Ramahi RJ, Aziz NA, Ghazali R (2009) Impact of a renal drug dosing service on dose adjustment in hospitalized patients with chronic kidney disease. Ann Pharmacother 43(10):1598\u20131605. https:\/\/doi.org\/10.1345\/aph.1M187","journal-title":"Ann Pharmacother"},{"issue":"12","key":"2834_CR33","doi-asserted-by":"publisher","first-page":"891","DOI":"10.3109\/00365548.2013.827338","volume":"45","author":"SP Jiang","year":"2013","unstructured":"Jiang SP, Zhu ZY, Ma KF, Zheng X, Lu XY (2013) Impact of pharmacist antimicrobial dosing adjustments in septic patients on continuous renal replacement therapy in an intensive care unit. Scand J Infect Dis 45(12):891\u2013899. https:\/\/doi.org\/10.3109\/00365548.2013.827338","journal-title":"Scand J Infect Dis"},{"issue":"4","key":"2834_CR34","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.medmal.2019.06.010","volume":"50","author":"B Aloy","year":"2020","unstructured":"Aloy B, Launay-Vacher V, Bleibtreu A et al (2020) Antibiotics and chronic kidney disease: dose adjustment update for infectious disease clinical practice. Med Mal Infect 50(4):323\u2013331. https:\/\/doi.org\/10.1016\/j.medmal.2019.06.010","journal-title":"Med Mal Infect"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-021-02834-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-021-02834-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-021-02834-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T11:38:06Z","timestamp":1641382686000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-021-02834-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,18]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["2834"],"URL":"https:\/\/doi.org\/10.1007\/s11255-021-02834-6","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,18]]},"assertion":[{"value":"17 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The author declares no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Ethical approval was obtained for the study (Ref: INV-2017\u2013306).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publication"}}]}}